- Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
-
Naeem Z, Allan S, Hernandez A, Galanakis DK, Singer AJ
- KMID: 2517602
- Clin Exp Emerg Med.
- 2021 Jun;8(2):75-81.
- doi: 10.15441/ceem.20.017
Objective Four-factor prothrombin complex concentrate (4F-PCC) was approved by the US Food and Drug Administration in 2013 for management of severely bleeding patients on warfarin therapy. We describe use of... -
- CITED
-
- Close
- SHARE
-
- Close
